CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Novast Laboratories, Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Novast Laboratories, Limited
Phone: +86 51385988868p:+86 51385988868 NANTONG, JNG  226010  China Ticker: 301569301569
Business Summary
Novast Laboratories, Limited is a China-based company primarily engaged in the research, development, production and sales of complex pharmaceutical preparations. The Company is mainly engaged in generic drugs and the provision of research and development and other services to pharmaceutical companies and research institutions. The Company's products include sustained-release and controlled-release preparations and low-dose drug preparations. The Company's products and services are mainly applied in hypertension, coronary heart disease, diabetes, schizophrenia, female contraception and health fields. The Company mainly operates overseas and in domestic markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202612/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

General Information
Number of Employees: 697 (As of 12/31/2025)
Outstanding Shares: 891,597,091 (As of 10/15/2026)
Stock Exchange: SHE
Fax Number: +86 51385986619


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 14, 2026